Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Nucl Med Biol. 2016 Jul 30;43(12):812–817. doi: 10.1016/j.nucmedbio.2016.07.008

Figure 2.

Figure 2

The biodistribution of radioactivity post-injection across selected SCID mouse organs following the administration of 188Re-labeled IGF2R-specific mAb (MEM-238) and 188Re-labeled control mAb (MOPC21): A) 24 hrs; B) 48 hrs